By Liliana Salgado PHOENIX (Reuters) -A global pattern of heat waves scorching parts of Europe, Asia and the United States intensified on Tuesday, with the […]
J&J sues in latest bid to halt Medicare drug price negotiations
(Reuters) -Johnson & Johnson sued the U.S. government on Tuesday, becoming the latest drugmaker seeking to block a program that gives the Medicare government health […]
Teladoc expands Microsoft tie-up to document patient visits with AI
(Reuters) – Teladoc Health is expanding a partnership with Microsoft to use the tech giant’s artificial intelligence services to automate clinical documentation on the telehealth […]
Pfizer, Flagship Pioneering to invest $100 million in drug discovery
(Reuters) -U.S. drugmaker Pfizer and venture firm Flagship Pioneering on Tuesday said they would invest $100 million together to develop up to 10 new potential […]
Childhood vaccination rates begin to recover post-pandemic – but not everywhere, U.N. says
By Jennifer Rigby LONDON (Reuters) – Efforts to vaccinate children worldwide against deadly diseases such as measles and diphtheria began to recover in 2022 after […]
Explainer-The health risks of extreme heat
By Jennifer Rigby and Kate Turton LONDON (Reuters) – The world is baking under extreme heat – with Asia, Europe and the United States all […]
Experimental drug works best for Alzheimer’s patients treated as early as possible
By Deena Beasley (Reuters) -An experimental drug from Eli Lilly works best if Alzheimer’s patients are treated as early as possible, ideally before they develop […]
AT&T shares hit three-decade low as lead cables risk weighs
By Chibuike Oguh NEW YORK (Reuters) -Shares of AT&T Inc fell nearly 7% to hit their lowest level in thirty years on Monday, after analysts […]
US FDA approves Sanofi-AstraZeneca’s preventive RSV therapy for babies
(Reuters) -The U.S. Food and Drug Administration (FDA) said on Monday it had approved Sanofi and partner AstraZeneca’s antibody therapy to prevent respiratory syncytial virus […]
Acumen’s Alzheimer’s drug passes initial safety test
By Julie Steenhuysen CHICAGO (Reuters) – An experimental Alzheimer’s disease drug developed by Acumen Pharmaceuticals targeting a novel form of the toxic protein beta amyloid […]